{"id":"https://openalex.org/W4288758587","doi":"https://doi.org/10.1038/s41386-022-01393-3","title":"Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats","display_name":"Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats","publication_year":2022,"publication_date":"2022-07-29","ids":{"openalex":"https://openalex.org/W4288758587","doi":"https://doi.org/10.1038/s41386-022-01393-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/35906489","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9556538"},"language":"en","primary_location":{"id":"doi:10.1038/s41386-022-01393-3","doi":"https://doi.org/10.1038/s41386-022-01393-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-022-01393-3","pdf_url":"https://www.nature.com/articles/s41386-022-01393-3.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nature.com/articles/s41386-022-01393-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010598215","display_name":"E. Andrew Townsend","orcid":"https://orcid.org/0000-0002-7139-3273","observed_orcids":["https://orcid.org/0000-0002-7139-3273"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"E. Andrew Townsend","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. edward.townsend@vcuhealth.org","Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7139-3273","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. edward.townsend@vcuhealth.org","institution_ids":["https://openalex.org/I184840846"]},{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076847254","display_name":"Bruce E. Blough","orcid":"https://orcid.org/0000-0003-3515-0896","observed_orcids":["https://orcid.org/0000-0003-3515-0896"]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce E. Blough","raw_affiliation_strings":["Center for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Discovery, RTI International, Research Triangle Park, Durham, NC, USA","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040672500","display_name":"David H. Epstein","orcid":"https://orcid.org/0000-0001-8147-0386","observed_orcids":["https://orcid.org/0000-0001-8147-0386"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David H. Epstein","raw_affiliation_strings":["Intramural Research Program, NIDA, NIH, Baltimore, MD, USA"],"raw_orcid":"https://orcid.org/0000-0001-8147-0386","affiliations":[{"raw_affiliation_string":"Intramural Research Program, NIDA, NIH, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086044481","display_name":"S. Stevens Negus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Stevens Negus","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066436685","display_name":"Yavin Shaham","orcid":"https://orcid.org/0000-0002-8242-3319","observed_orcids":["https://orcid.org/0000-0002-8242-3319"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yavin Shaham","raw_affiliation_strings":["Intramural Research Program, NIDA, NIH, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intramural Research Program, NIDA, NIH, Baltimore, MD, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023437507","display_name":"Matthew L. Banks","orcid":"https://orcid.org/0000-0003-4949-5246","observed_orcids":["https://orcid.org/0000-0003-4949-5246"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew L. Banks","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA"],"raw_orcid":"https://orcid.org/0000-0003-4949-5246","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010598215"],"corresponding_institution_ids":["https://openalex.org/I184840846"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":2.4269,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.88291145,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"47","issue":"12","first_page":"2132","last_page":"2139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trv130","display_name":"TRV130","score":0.9449999928474426},{"id":"https://openalex.org/keywords/oliceridine","display_name":"oliceridine","score":0.9169999957084656},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8510000109672546},{"id":"https://openalex.org/keywords/mu-opioid-receptor-agonists","display_name":"mu-opioid receptor agonists","score":0.9110000133514404},{"id":"https://openalex.org/keywords/food-choice","display_name":"food choice","score":0.8109999895095825},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.6959999799728394},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.8169999718666077}],"concepts":[{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.9214093089103699},{"id":"https://openalex.org/C2781072394","wikidata":"https://www.wikidata.org/wiki/Q407541","display_name":"Fentanyl","level":2,"score":0.90919029712677},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.8411089181900024},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6087425947189331},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.5739591717720032},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5413427948951721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5069801807403564},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47920140624046326},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.45006975531578064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2594899535179138},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18792372941970825}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005283","descriptor_name":"Fentanyl","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013141","descriptor_name":"Spiro Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41386-022-01393-3","doi":"https://doi.org/10.1038/s41386-022-01393-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-022-01393-3","pdf_url":"https://www.nature.com/articles/s41386-022-01393-3.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9556538","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9556538","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"Text"},{"id":"pmid:35906489","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35906489","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41386-022-01393-3","doi":"https://doi.org/10.1038/s41386-022-01393-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41386-022-01393-3","pdf_url":"https://www.nature.com/articles/s41386-022-01393-3.pdf","source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","score":0.49000000953674316,"display_name":"Zero hunger"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G366177849","display_name":null,"funder_award_id":"R01DA026946","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G4666949252","display_name":"The Central Virginia Center on Drug Abuse Research","funder_award_id":"P30DA033934","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6423728032","display_name":null,"funder_award_id":"P30DA033934","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G838984340","display_name":"Medications Development for Stimulant Abuse","funder_award_id":"R01DA026946","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4288758587.pdf","grobid_xml":"https://content.openalex.org/works/W4288758587.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1981935824","https://openalex.org/W1989611146","https://openalex.org/W1996107599","https://openalex.org/W2025778747","https://openalex.org/W2056567448","https://openalex.org/W2056960642","https://openalex.org/W2061007797","https://openalex.org/W2065535329","https://openalex.org/W2065728615","https://openalex.org/W2099229435","https://openalex.org/W2103431332","https://openalex.org/W2114779627","https://openalex.org/W2116745456","https://openalex.org/W2119437260","https://openalex.org/W2132974770","https://openalex.org/W2134939120","https://openalex.org/W2151491015","https://openalex.org/W2161018183","https://openalex.org/W2161169589","https://openalex.org/W2164822993","https://openalex.org/W2165671231","https://openalex.org/W2172107654","https://openalex.org/W2243000384","https://openalex.org/W2302990640","https://openalex.org/W2506882304","https://openalex.org/W2512819857","https://openalex.org/W2559087812","https://openalex.org/W2567677633","https://openalex.org/W2584711061","https://openalex.org/W2767916367","https://openalex.org/W2890117474","https://openalex.org/W2909614706","https://openalex.org/W2910665649","https://openalex.org/W2913484886","https://openalex.org/W2931545531","https://openalex.org/W2943075664","https://openalex.org/W2944766175","https://openalex.org/W2995849817","https://openalex.org/W2999178958","https://openalex.org/W3000326077","https://openalex.org/W3005454586","https://openalex.org/W3015123576","https://openalex.org/W3037188045","https://openalex.org/W3038556879","https://openalex.org/W3093488015","https://openalex.org/W3094090974","https://openalex.org/W3133466315","https://openalex.org/W3133617384","https://openalex.org/W3158282101","https://openalex.org/W3198731063","https://openalex.org/W3212661576","https://openalex.org/W3216869366","https://openalex.org/W4210253499","https://openalex.org/W4225272835"],"related_works":["https://openalex.org/W3164920896","https://openalex.org/W3201517998","https://openalex.org/W2071661571","https://openalex.org/W2099229435","https://openalex.org/W2032216247","https://openalex.org/W4225402032","https://openalex.org/W2015667857","https://openalex.org/W3023048099","https://openalex.org/W4405796823","https://openalex.org/W3150289201"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-07-30T00:00:00"}